OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - EDWARDS LIFESCIENCES | Market Closed - Deutsche Boerse AG 20:51:01 25/06/2024 BST | ||
| 3.43 EUR | +1.18% |
|
| Current month | +15.10% | ||
| 1 month | +8.89% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 25/06/24 | 3.43 | +1.18% |
| 24/06/24 | 3.39 | -0.29% |
| 21/06/24 | 3.4 | +0.89% |
| 20/06/24 | 3.37 | +6.98% |
| 19/06/24 | 3.15 | -2.78% |
Delayed Quote Deutsche Boerse AG
Last update June 25, 2024 at 08:51 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SW2G5V |
| ISIN | DE000SW2G5V7 |
| Date issued | 21/08/2023 |
| Strike | 54.05 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.54 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.97 € |
|---|---|
| Lowest since issue | 0.95 € |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
91.08
USD
Average target price
96.05
USD
Spread / Average Target
+5.46%
- Stock Market
- Certificates
- Certificat
